Vaccination experiments were carried out in Ethiopia to study the efficacy of the NDV-I 2 vaccine against challenge with an Ethiopian velogenic strain of NDV. In experiment A, which comprised 300 broiler chicks, the efficacy of the ocular/drinking water application of the HB1/La Sota vaccine was compared with the ocular/drinking water and the feed application of the NDV-I 2 vaccine on untreated barley and sorghum. The NDV-I 2 vaccine applied by eye-drop or drinking-water protected the chickens against challenge as efficiently as combined HB1/La Sota vaccination but untreated barley and sorghum were unsuitable vaccine carriers. The vaccine virus could not be recovered and chickens neither seroconverted nor were they protected. In experiment B, 120 broiler chicks were divided into 6 treatment groups. One group each received NDV-I 2 vaccine mixed with untreated barley or sorghum which was applied immediately, or 14 h after mixing and standing at ambient temperature. The fifth group was vaccinated intraocularly and via the drinking water with the NDV-I 2 vaccine. The sixth group remained untreated. Experiment B confirmed the results of experiment A. In experiment C, 100 chicks were divided into 5 groups of 20 chickens each. One group each received the NDV-I 2 vaccine on parboiled barley or sorghum as vaccine carriers 0 and 6 h after mixing. The last group remained untreated. Parboiled barley given 0 or 6 h and parboiled sorghum given 0 h after mixing with the vaccine led to seroconversion and protection of the chickens. Parboiled sorghum given 6 h after mixing with the vaccine did not. It is concluded that the thermostable NDV-I 2 vaccine may be a suitable vaccine for oral application under Ethiopian conditions.
During the period 1988 to 1991 samples from 16 foot-and-mouth disease outbreaks in Ethiopia were examined at the National Veterinary Institute, Ethiopia, and at the FAO World Reference Laboratory for Foot-and-Mouth Disease, UK. Typing of the virus responsible was possible in 13 of these outbreaks representing 10 separate disease events; 8 of these were caused by serotype O and 2 by serotype SAT2. This is the first record of the presence of serotype SAT2 foot-and-mouth disease virus in Ethiopia. In contrast to earlier studies serotypes A and C were not detected.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.